Form 4: Enovix Director Exercises Warrants, Boosts Stake
Insider Transaction Report
Enovix Corp Director and 10% owner Thurman J. Rodgers exercised 220,114 warrants at $8.75 per share, increasing his beneficial ownership.
Summary
- Thurman J. Rodgers, a Director and 10% Owner of Enovix Corp (ENVX), exercised 220,114 publicly-traded warrants on August 11, 2025.
- The warrants were exercised at a price of $8.75 per share, resulting in the acquisition of 220,114 shares of Common Stock.
- The shares were issued to the Rodgers Family Freedom and Free Markets Charitable Trust, for which Rodgers serves as a trustee with voting and dispositive power.
- The warrants were originally distributed by Enovix Corp on July 21, 2025, at no cost to the reporting person.
- Following this transaction, Rodgers' beneficial ownership includes 1,120,114 shares held indirectly by the Rodgers Family Freedom and Free Markets Charitable Trust, 20,858,407 shares held indirectly by the Rodgers Massey Revocable Living Trust, and 22,543 shares held directly from restricted stock units (RSUs).
- The warrants have an exercise price of $8.75 per share and are exercisable from July 21, 2025, until their expiration on October 1, 2026, subject to potential early acceleration.
Sentiment
Score: 8
Explanation: The exercise of warrants by a director and 10% owner, increasing their stake, is a strong positive signal of confidence in the company's future performance and valuation.
Positives
- A Director and 10% owner increasing their stake in the company through warrant exercise signals strong insider confidence in Enovix Corp's future performance.
- The warrants were distributed at no cost to the reporting person, making the exercise a strategic move to acquire shares at a fixed price.
Risks
- The warrants held by the reporting person will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026, unless subject to automatic acceleration upon satisfaction of an early expiration price condition as defined in the Warrant Agreement.
Future Outlook
The filing indicates a pre-planned transaction under Rule 10b5-1(c), signaling a future increase in insider ownership.
Industry Context
N/A
Related Party Transactions
- The transaction involves Thurman J. Rodgers, a Director and 10% Owner of Enovix Corp, exercising warrants issued by the company, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders: The increase in beneficial ownership by a director and 10% owner signals strong insider confidence, potentially boosting investor sentiment.
- Employees, Customers, Suppliers, Creditors: No direct or immediate impact from this specific insider transaction.
Next Steps
- The remaining warrants held by the reporting person will expire on October 1, 2026, unless exercised or subject to early acceleration.
Key Dates
| Date | Description |
|---|---|
| 04/04/2011 | Date of the Rodgers Massey Revocable Living Trust. |
| 07/21/2025 | Warrants were distributed by the Issuer and became exercisable. |
| 08/11/2025 | Transaction Date: Exercise of publicly-traded warrants. |
| 08/12/2025 | Filing Date of the Form 4. |
| 10/01/2026 | Warrant Expiration Date. |
Recommendation
buyThe significant increase in beneficial ownership by a director and 10% owner through the exercise of warrants at a fixed price indicates strong insider confidence in Enovix Corp's future prospects. This insider buying activity is generally viewed as a bullish signal for investors.
Keywords
Enovix, ENVX, SEC Form 4, Insider Trading, Warrant Exercise, Director Ownership, Stock Acquisition, Thurman J. Rodgers, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.